Akebia Therapeutics Inc (AKBA.OQ)
AKBA.OQ on NASDAQ Stock Exchange Global Market
3.94USD
5:20pm BST
3.94USD
5:20pm BST
Change (% chg)
$-0.11 (-2.72%)
$-0.11 (-2.72%)
Prev Close
$4.05
$4.05
Open
$4.03
$4.03
Day's High
$4.06
$4.06
Day's Low
$3.84
$3.84
Volume
129,447
129,447
Avg. Vol
403,556
403,556
52-wk High
$10.73
$10.73
52-wk Low
$3.84
$3.84
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Adrian Adams |
68 | 2018 | Independent Chairman of the Board |
John Butler |
54 | 2013 | President, Chief Executive Officer, Director |
Jason Amello |
50 | 2013 | Chief Financial Officer, Senior Vice President, Treasurer |
Nicole Hadas |
46 | 2013 | Senior Vice President, Chief Legal Officer and Secretary |
Steven Burke |
57 | 2019 | Senior Vice President, Chief Medical Officer |